Efficacy and Safety of Benralizumab for Patients with Severe Asthma Uncontrolled with High-Dosage Inhaled Corticosteroids and Long-acting b2-agonists (SIROCCO): A Randomised, Multicentre, Placebo-Controlled Phase 3 Trial

Daniel Har, J. Andrew Bird

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S224-S225
JournalPediatrics
Volume140
DOIs
StatePublished - Dec 1 2017

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this